Trade Mark Journal No.2026/003 16 January 2026
WO0000001893407 (42)
Office of origin: United States of America
Date of International Registration:26 November 2025
Date of designation in the UK:
26 November 2025

- Class 42
- Research and development of pharmaceuticals; scientific research and development of therapies in the fields of biotechnology, genetic medicine, gene therapy, biologics, small molecules, DNA, RNA, proteins, vectors and payloads; pharmaceutical products design and development for medical and scientific use, and medical treatment; pharmaceutical drug design and development featuring biomolecules.
4D MOLECULAR THERAPEUTICS INC.
Representative: Adam K Sacharoff Much Shelist, PC, 191 N Wacker Drive, Suite 1800, Chicago IL 60606, UNITED STATES OF AMERICA